Clinical diagnosis compared to classification criteria in a cohort of 54 patients with systemic sclerosis and associated disorders

Swiss Medical Weekly

Volumn 137, Issue 41-42, 2007, Pages 586-590

  Ziswiler, Hans Rudolf ^a   Urech, Romana ^a   Balmer, Judith ^a   Ostensen, Monika ^a   Mieru, Rudolf ^b   Villiger, Peter M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Rheumaklinik und Rheumaforschungsinstitut Aachen   (Germany)

Author keywords

Antinuclear antibody; Cohort; Nailfold capillary microscopy; Raynaud's phenomen; Scleroderma; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; CENTROMERE ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MIXED CONNECTIVE TISSUE DISEASE; PHYSICAL EXAMINATION; RAYNAUD PHENOMENON; SYSTEMIC SCLEROSIS;

EID: 35548998420     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Masi AT, Rodnan GP, Medsger TA Jr, et al. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581-90.
2. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15 (2):202-5.
3. Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum. 1994;37(1):75-83.
4. Reimer G, Steen VD, Penning CA, Medsger TA Jr, Tan EM. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum. 1988;31(4):525-32.
5. Kane GC, Varga J, Conant EF, Spirn PW, Jimenez S, Fish JE. Lung involvement in systemic sclerosis (scleroderma): relation to classification based on extent of skin involvement or autoantibody status. Respir Med. 1996;90(4):223-30.
6. Steen VD, Powell DL, Medsger TA Jr. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum. 1988;31(2):196-203.
7. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001;28(7):1573-6. Review.
8. Schmidt JA, Caspary L, von Bierbrauer A, Ehrly AM, Junger M, Jung F, Lawall H. Standardization of nailfold capillary microscopy in routine diagnosis. Vasa. 1997;26(1):5-10. Review. German.
9. Hunzelmann N, Krieg T, Untersuchungs- und Verlaufbogen Netzwerk Sklerodermie 01/2001.
10. Clements PJ, Lachenbruch PA, Ng SC, Simmons M, Sterz M, Furst DE. Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum. 1990;33(8):1256-63.
11. Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter- and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22(7):1281-5.
12. Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol. 1993;20(11):1892-6.
13. Bollinger A, Fagrell B. Clinical capillaroscopy. Toronto Hogrefe and Huber. 1990.
14. Dick T, Mierau R, Sternfeld R, Weiner EM, Genth E. Clinical relevance and HLA association of autoantibodies against the nucleolus organizer region (NOR-90). J Rheumatol. 1995;22 (1):67-72.
15. Genth E, Mierau R, Genetzky P, von Muhlen CA, Kaufmann S, von Wilmowsky H, et al. Immunogenetic associations of scleroderma-related antinuclear antibodies. Arthritis Rheum. 1990;33(5):657-65.
16. Mierau R, Dick T, Bartz-Bazzanella P, Keller E, Albert ED, Genth E. Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR beta chain. Arthritis Rheum. 1996;39(5):868-76.
17. Dick T, Mierau R, Bartz-Bazzanella P, Alavi M, Stoyanova-Scholz M, Kindler J, Genth E. Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis. Ann Rheum Dis. 2002;61(2):121-7. Review.
18. Maricq HR, LeRoy EC, D'Angelo WA, Medsger TA Jr, Rodnan GP, Sharp GC, et al. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum. 1980;23(2):183-9.
19. Cutolo M, Pizzorni C, Tuccio M, Burroni A, Craviotto C, Basso M, et al. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford). 2004.
20. Lovy M, MacCarter D, Steigerwald JC. Relationship between nailfold capillary abnormalities and organ involvement in systemic sclerosis. Arthritis Rheum. 1985;28(5):496-501.
21. Maricq HR, Spencer-Green G, LeRoy EC. Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis. Am J Med. 1976;61(6):862-70.
22. Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G,et al. Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc). Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore). 2002;81(2):139-53. Review.
23. Della Rossa A, Valentini G, Bombardieri S, Bencivelli W, Silman AJ, D'Angelo S, et al. European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Ann Rheum Dis. 2001;60(6):585-91.
24. Allcock RJ, Forrest I, Corris PA, Crook PR, Griffiths ID. A study of the prevalence of systemic sclerosis in northeast England. Rheumatology (Oxford). 2004;43(5):596-602. Epub 2004 Feb 10. Review.
25. Le Guern V, Mahr A, Mouthon L, Jeanneret D, Carzon M, Guillevin L. Prevalence of systemic sclerosis in a French multiethnic county. Rheumatology (Oxford). 2004;43(9):1129-37. Epub 2004 Jun 22.
26. Thompson AE, Pope JE. Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis. J Rheumatol. 2002; 29(9):1867-73.
27. Geirsson AJ, Steinsson K, Guthmundsson S, Sigurthsson V. Systemic sclerosis in Iceland. A nationwide epidemiological study. Ann Rheum Dis. 1994;53(8):502-5.
28. Walker UA, Tyndall A, Czirjak L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis. 2007;66(6):754-63. Epub 2007 Jan 18.